Bivalirudin Injection, Powder, Lyophilized, For Solution
Product Images NDC 67457-256

2 FDA label images from Mylan Institutional Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 67457-256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bivalirudin For Injection 250 mg/vial Carton Label (Image 01)

Bivalirudin For Injection 250 mg/vial Carton Label (Image 01)
Packaging label for Bivalirudin for Injection 250 mg/vial, lyophilized powder for solution, by Mylan Institutional LLC. The label indicates 10 single-dose vials, for intravenous use only, and includes storage and manufacturing details. The NDC number 67457-256-10 is visible along with the Mylan logo.*
FDA Label Image

Figure 1: Structural Formula For Bivalirudin Trifluoroacetate (Image 02)

Figure 1: Structural Formula For Bivalirudin Trifluoroacetate (Image 02)
Chemical structure of bivalirudin showing its peptide backbone and side chains, including phenylalanine and other amino acid residues. The diagram includes the range of counterion molecules represented as CF3CO2H with variable stoichiometry (x = 1.7-2.6).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.